Ligand validation:7T8F

9JT: N-phenyl-2-selanylbenzamide

9JT is a Ligand Of Interest in 7T8F designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7T8F_9JT_F_202	51%	1%	0.205	0.96	6.65	1.55	4	4	0	0	100%	0.8875
7T8F_9JT_A_203	44%	1%	0.201	0.931	6.43	1.94	4	6	0	0	100%	0.8938
6SPH_9JT_E_202	87%	1%	0.102	0.976	6.47	1.22	2	3	1	0	100%	0.85
5O40_9JT_A_503	55%	1%	0.155	0.924	6.68	1.22	2	1	0	0	100%	0.7
6Z4G_9JT_AAA_204	43%	1%	0.231	0.955	6.77	1.41	4	3	1	0	100%	1
6RRM_9JT_B_503	81%	29%	0.124	0.976	1.76	1.11	3	2	0	0	100%	1
7B6P_9JT_A_501	81%	60%	0.101	0.952	0.7	0.81	1	1	0	0	100%	1
6ZK0_9JT_AAA_312	72%	30%	0.118	0.942	1.05	1.71	1	1	0	0	100%	0.5844
8EJX_9JT_A_201	63%	28%	0.151	0.948	1.99	0.92	4	1	0	0	100%	1
8GMI_9JT_B_402	59%	27%	0.147	0.928	1.95	1	4	1	0	0	100%	0.83

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.